Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-15

Clinical Trial Update: Study of the AFB and Stenting of the Iliac Arteries [Phase 1]

View source ↗

Summary

Phase 1 study evaluating AFB and iliac artery stenting for aortoiliac segment lesions (TASC II C/D) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Aorta-iliac Segment Lesion (C,D Type by TASC II) | Phase 1 | Status: COMPLETED